Selected article for: "anti activity and cell addition"

Author: Sun, Wei; Fang, Mingli; Chen, Yajing; Yang, Zhaogang; Xiao, Yue; Wan, Min; Wang, Hua; Yu, Yongli; Wang, Liying
Title: Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice
  • Cord-id: sxidmw7e
  • Document date: 2016_1_5
  • ID: sxidmw7e
    Snippet: Purpose: In order to improve the immunogenicity of whole tumor cell lysate for tumor vaccine, we have designed a series of CpG ODNs to study their transport and to evaluate their anti-tumor activity in B16 melanoma mouse models. Methods: In this study, we investigated whether C-class CpG ODN (CpG ODN-685) could facilitate tumor cell lysate to induce vigorous anti-tumor activity against tumors in mice both prophylactically and therapeutically. Results: It was found that the combination of tumor c
    Document: Purpose: In order to improve the immunogenicity of whole tumor cell lysate for tumor vaccine, we have designed a series of CpG ODNs to study their transport and to evaluate their anti-tumor activity in B16 melanoma mouse models. Methods: In this study, we investigated whether C-class CpG ODN (CpG ODN-685) could facilitate tumor cell lysate to induce vigorous anti-tumor activity against tumors in mice both prophylactically and therapeutically. Results: It was found that the combination of tumor cell lysate and CpG ODN-685 could inhibit the growth of B16 melanoma and prolong the survival of tumor-bearing mice. Moreover CpG ODN-685 with the addition of tumor cell lysate can also cause the generation of tumor specific immune memory by inducing specific cytotoxic T lymphocytes and helper T lymphocytes in mice. Conclusion: The results suggest that CpG ODN-685 could be developed as an efficient adjuvant for tumor vaccines against melanoma.

    Search related documents:
    Co phrase search for related documents
    • adaptive immune response and local site: 1
    • adaptive immune response and low affinity: 1
    • adaptive immune response and lymph node: 1, 2, 3, 4, 5, 6
    • adaptive immune response and lymphocyte increase: 1
    • local site and lymph node: 1